Skip to main content
. 2020 Apr 7;10:414. doi: 10.3389/fonc.2020.00414

Table 3.

List of side-effects grouped by grade.

Grade 1-2 Grade 3-4 All grade
no. (%) no. (%) no. (%)
Haematological side-effects
Anaemia 16 (80.0) 4 (20.0) 20 (100)
Neutropoenia 40 (87.0) 6 (13.0) 46 (100)
Thrombocytopoenia 34 (97.1) 1 (2.9) 35 (100)
Non-haematological side-effects
Abdominal pain 45 (91.8) 4 (8.2) 49 (100)
Alkaline phosphatase 9 (90.0) 1 (10.0) 10 (100)
Alopoecia 7 (100) 0 7 (100)
Anorexia 34 (94.4) 2 (5.6) 36 (100)
AST/ALT increase 124 (83.8) 24 (16.2) 148 (100)
Asthenia 30 (81.1) 7 (18.9) 37 (100)
Blood bilirubin increase 29 (93.5) 2 (6.5) 31 (100)
Confusion 0 1 (100) 1 (100)
Constipation 8 (100) 0 8 (100)
Dehydration 0 1 (100) 1 (100)
Diarrhoea 114 (89.8) 13 (10.2) 127 (100)
Dizziness 7 (100) 0 7 (100)
Oedema 9 (100) 0 9 (100)
Erythema 5 (100) 0 5 (100)
Fatigue 103 (89.6) 12 (10.4) 115 (100)
Fever 7 (100) 0 7 (100)
H&F syndrome 34 (94.4) 2 (5.6) 36 (100)
Hair depigmentation 11 (100) 0 11 (100)
Headache 17 (100) 0 17 (100)
Hepatotoxicity 8 (53.3) 7 (46.7) 15 (100)
High GGT 5 (100) 0 5 (100)
High LDH 7 (100) 0 7 (100)
Hyperglycaemia 15 (83.3) 3 (16.7) 18 (100)
Hypertension 79 (68.7) 36 (31.3) 115 (100)
Hypertriglyceridaemia 0 1 (100) 1 (100)
Hypocalcaemia 7 (100) 0 7 (100)
Hypokalaemia 1 (50) 1 (50) 2 (100)
Hypomagnesaemia 9 (100) 0 9 (100)
Hypophosphataemia 5 (100) 0 5 (100)
Hyporexia 7 (87.5) 1 (12.5) 8 (100)
INR increase 7 (100) 0 7 (100)
Insomnia 5 (100) 0 5 (100)
Mucositis 37 (100) 0 37 (100)
Nausea 123 (96.1) 5 (3.9) 128 (100)
Pain 19 (90.5) 2 (9.5) 21 (100)
Pancreatitis 0 1 1 (100)
Proteinuria 7 (63.6) 4 (36.4) 11 (100)
Pruritus 4 (100) 0 0 (100)
Rash 18 (94.7) 1 (5.3) 19 (100)
Skin and subcutaneous tissue disorders 6 (100) 0 6 (100)
Skin hypopigmentation 7 (100) 0 7 (100)
Drowsiness 6 (100) 0 6 (100)
Thromboembolic events 0 1 (100) 1 (100)
Urinary tract infection 0 1 (100) 1 (100)
Vomiting 41 (9.1) 4 (8.9) 45 (100)